MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Dysautonomia and cognitive impairment in Essential Tremor: is there a link?

A. Rekik, A. Nasri, S. Mrabet, M. Bendjebara, A. Gargouri, I. Kacem, R. Gouider (Manouba, Tunisia)

Meeting: MDS Virtual Congress 2021

Abstract Number: 1360

Keywords: Autonomic dysfunction, Cognitive dysfunction, Essential tremor(ET)

Category: Tremor

Objective: To investigate the relationship between autonomic dysfunction and cognitive impairment in Essential Tremor (ET).

Background: Even though the term ‘essential’ was used to reflect the motor side of ET, it is now admitted that autonomic dysfunction and cognitive impairment are classic in these patients. However, their underlying mechanisms and potential dynamics remain unclear.

Method: We conducted a cross-sectional study in the department of Neurology in Razi University hospital including patients diagnosed with ET syndrome and ET-plus syndrome as defined by the classification of tremor by MDS 2018. Autonomic function was measured using the SCOPA-Aut questionnaire. All patients had a neuropsychological assessment including Mini Mental Status Examination (MMSE) to assess global cognitive function and the Frontal Assessment Battery (FAB) for executive function.

Results: We included 107 ET patients (sex ratio =1; mean age of onset = 56 + 16 years).Autonomic dysfunction was present in 75 % of cases (bladder dysfunction in 54.2%;cardiovascular dysfunction in 42 % and gastrointestinal dysfunction in 40%). Cognitive impairment was present in 39.3% of cases (dementia in 16.8% and mild cognitive impairment in 22.5%). Mean MMSE score was of 26.5 and mean FAB score was of 13. Memory was the main affected cognitive domain (48%) followed by executive function (44.3%). Memory impairment was positively correlated to gastrointestinal dysfunction (p=0.044). No other correlations were established between other dysautonomic signs and cognitive dysfunction findings.

Conclusion: We found a high prevalence of dysautonomic features and cognitive deficits in ET patients. The association between memory impairment and gastrointestinal dysfunction in ET patients, also established in early stages of Parkinson’s disease,may recall the progression pattern of neurodegenerative diseases.

To cite this abstract in AMA style:

A. Rekik, A. Nasri, S. Mrabet, M. Bendjebara, A. Gargouri, I. Kacem, R. Gouider. Dysautonomia and cognitive impairment in Essential Tremor: is there a link? [abstract]. Mov Disord. 2021; 36 (suppl 1). https://www.mdsabstracts.org/abstract/dysautonomia-and-cognitive-impairment-in-essential-tremor-is-there-a-link/. Accessed May 13, 2025.
  • Tweet
  • Email
  • Print

« Back to MDS Virtual Congress 2021

MDS Abstracts - https://www.mdsabstracts.org/abstract/dysautonomia-and-cognitive-impairment-in-essential-tremor-is-there-a-link/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley